发明名称 |
CATIONIC LIPID CORDIARIMIDE HYBRID COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF |
摘要 |
<p>The present invention relates to the cationic lipid cordiaroimide hybrid compounds of formula I. The present invention provides a process for preparation of these compounds is also being elaborated. The compounds described provides anticancerous activity against cell lines including PC-3 (prostate cancer), HepG2 (liver cancer), MCF-7 (breast cancer) and NIH/3T3 (non cancer) cells. The compound was also capable of inducing caspase-3 mediated apoptosis in HepG2 cells by arresting the cell cycle in the G1 phase. Furthermore, the compound exhibited DNA ligase I inhibition. The present class of cationic lipid cordiarimide hybrids is likely to find specific use in developing novel targeted therapies for liver and prostate cancers.</p> |
申请公布号 |
WO2015189856(A1) |
申请公布日期 |
2015.12.17 |
申请号 |
WO2015IN00235 |
申请日期 |
2015.06.10 |
申请人 |
COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
发明人 |
REDDY, BATHULA SURENDAR;RAO, V.K.K. DURGA;SHARMA, KOMAL;REDDY, M. PRATHAP;BANERJEE, DIBYENDU;SINGH, DEEPENDRA KUMAR |
分类号 |
C07D211/88;A61K31/4412;A61P35/00 |
主分类号 |
C07D211/88 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|